Quantification of Platelet Contractile Movements during Thrombus Formation

Descarga: Quantification of Platelet Contractile Movements during Thrombus Formation Archivo: tromboembolia-venosa/TH set 2018 quantification of.pdf Imaging methods based on time-lapse micro scopy are important tools for studying the dynamic events that shape thrombus formation upon vascular injury. However, there is a lack of methods to translate the vast amount of visual data generated in such…

Leer más

International Council for Standardization in Haematology (ICSH) Recommendations for Laboratory Measurement of Direct Oral Anticoagulants

Descarga: International Council for Standardization in Haematology (ICSH) Recommendations for Laboratory Measurement of Direct Oral Anticoagulants Archivo: guias/Tr Haemost 2018 Gosseline recomendations.pdf This guidance document was prepared on behalf of the International Council for Standardization in Haematology (ICSH) for providing haemostasis-related guidance documents for clinical laboratories. This inaugural coagulation ICSH document was developed by an…

Leer más

Apixaban to Prevent Venous Thromboembolism in Patients with Cancer

Descargar PDF — Apixaban to Prevent Venous Thromboembolism in Patients with Cancer BACKGROUNDPatients with active cancer have an increased risk of venous thromboembolism, which results in substantial morbidity, mortality, and health care expenditures. The Khorana score (range, 0 to 6, with higher scores indicating a higher risk of venous thromboembolism) has been validated to identify…

Leer más

STATE OF THE ART ISTH2017 BERLIN Anticoagulant prophylaxis and therapy in children: current challenges and emerging issues

Descarga: STATE OF THE ART ISTH2017 BERLIN Anticoagulant prophylaxis and therapy in children: current challenges and emerging issues Archivo: tromboembolia-venosa/infancia/jth 2018 anticoag children.pdf Summary.This review is aimed at describing the unique challenges of anticoagulant prophylaxis and treatment in children, and highlighting areas for research for improving clinical outcomes of children with thromboembolic disease. The evidence…

Leer más

Thrombosis as an intravascular effector of innate immunity

Descarga: Thrombosis as an intravascular effector of innate immunity Archivo: tromboembolia-venosa/engelmann2012 inmunotrombosis.pdf Abstract | Thrombosis is the most frequent cause of mortality worldwide and is closely linked to haemostasis, which is the biological mechanism that stops bleeding after the injury of blood vessels. Indeed, both processes share the core pathways of blood coagulation and platelet…

Leer más

Current evidence of oral anticoagulant reversal: A systematic review

Descarga: Current evidence of oral anticoagulant reversal: A systematic review Archivo: guias/reversion/Thr Res 2018 current evidence of oral anticoagulation reversal.pdf Introduction: Approximately 4–6% of patients treated with oral anticoagulants (OAC) will suffer from major hemorrhage or be in need of urgent surgery necessitating anticoagulant reversal therapy. Several new oral anticoagulants and reversal agents have been…

Leer más

Early fibrinogen concentrate therapy for major haemorrhage in trauma (E-FIT 1): results from a UK multi-centre, randomised, double blind, placebo-controlled pilot trial

Descarga: Early fibrinogen concentrate therapy for major haemorrhage in trauma (E-FIT 1): results from a UK multi-centre, randomised, double blind, placebo-controlled pilot trial Archivo: eha/early Fg concentrate transfusion 2018.pdf Abstract Background: There is increasing interest in the timely administration of concentrated sources of fibrinogen to patients with major traumatic bleeding. Following evaluation of early cryoprecipitate…

Leer más

Antiplatelet effect of aspirin during 24 h in patients with type 2 diabetes without cardiovascular disease

Descarga: Antiplatelet effect of aspirin during 24 h in patients with type 2 diabetes without cardiovascular disease Archivo: tromboembolia-arterial/cardiopatia/Thr Res 2018 Vernstrom-asp y diabetes.pdf Introduction: The antiplatelet effect of low-dose aspirin in patients with type 2 diabetes (T2DM) without cardiovascular disease (CVD) has not been thoroughly explored. We investigated if  platelet aggregation increased during the…

Leer más

An update on factor XI structure and function

Descarga: An update on factor XI structure and function Archivo: tromboembolia-venosa/tvp/Thr Res 2018 Mohamed-FXI.pdf Factor XI (FXI) is the zymogen of a plasma protease, factor XIa (FXIa), that contributes to thrombin generation during blood coagulation by proteolytic activation of several coagulation factors, most notably factor IX (FIX). FXI is a homolog of prekallikrein (PK), a…

Leer más

WARFARIN & OTHER ORAL ANTICOAGULANTS GUIDELINES AND PROCEDURES

Descarga: WARFARIN & OTHER ORAL ANTICOAGULANTS GUIDELINES AND PROCEDURES Archivo: guias/reversion/GUIAS WARFARINA WORCESTERSHIRE UK.pdf  Introduction Anticoagulants are one of the classes of medicines most frequently identified as causing preventable harm and admission to hospital. Managing the risks associated with anticoagulants can reduce the chance of patients being harmed. This Trust Guideline is based on British…

Leer más